It is anticipated that the global fructosamine test market sales will reach a valuation of US$ 266.3 million in 2023 and expand at a compound yearly growth rate (CAGR) of 3.8% during the forecast period. The whole market valuation is therefore expected to increase from US$ 275.9 million in 2024 to US$ 399.9 million in 2034.
Several factors are anticipated to drive the growth of the fructosamine test industry over the assessment period. These include increasing incidence of diabetes and obesity, growing awareness about fructosamine testing, and rising need for efficient blood glucose monitoring diagnostic tests.
Fructosamine testing has become a widely used method for measuring blood glucose. It does not require fasting and can be helpful when an HbA1c test is unreliable.
There has been a sharp rise in cases of diabetes during the last few years. For instance, according to the International Diabetes Federation, around 537 million adults were living with diabetes in 2021. This, in turn, is expected to uplift demand for fructose tests.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7030
Fructosamine testing is an important method that helps medical professionals monitor glycemic management in diabetics. The growing demand for these monitoring technologies highlights the need to address the expanding diabetes epidemic. It also shows the critical role innovative approaches, such as fructosamine testing, play in treating and reducing the effects of this chronic condition.
Another notable trend is the growing focus on fructosamine point-of-care diagnostics, which provide quick and easy glycemic control monitoring at the patient’s location. This change speeds up the evaluation of fast-acting blood glucose levels, allowing for rapid medical choices.
Point-of-care testing minimizes the need for a large laboratory infrastructure by streamlining the diagnostic procedure and providing instant results. This trend supports proactive diabetes management by improving patient accessibility to timely healthcare information, which is the primary goal.
Point-of-care fructosamine tests are a major improvement in decentralized healthcare due to their accessibility and speed. They significantly promote quicker interventions and improve overall patient outcomes.
Key Takeaways:
- The global market for fructosamine test is set to attain a valuation of US$ 399.9 million in 2034
- By disease indication, the diabetes II segment held a market share of about 59.4% in 2023.
- By sample, the blood serum is expected to progress with a CAGR of 3.5%.
- By end-user, the hospitals segment accounted for a revenue share of 29.8% in 2023.
- North America dominates the global market with a share of around 31.5%.
- The United States market value totaled US$ 74.7 million in 2023.
- Demand in India is predicted to rise at 7.9% CAGR through 2034.
“The rising focus on personalized diabetes management and compliance with CLIA standards enhances the use of fructosamine tests in clinical laboratories. This, in turn, will boost the growth of the fructosamine test industry over the forecast period,”says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
The Top Key Companies Profiled in the Fructosamine Test Market
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- Fortress Diagnostics
- KAMIYA BIOMEDICAL COMPANY
- Abbexa
- Weldon Biotech, Inc.
- Eurolyser Diagnostica GmbH
- F. Hoffmann-La Roche Ltd
- Asahi Kasei Pharma Corporation (EKF DIAGNOSTICS)
- LifeSpan BioSciences, Inc
- Zhejiang Kangte Biotechnology Co., Ltd.
- Diazyme
- Abcam plc.
- Weldon Biotech, Inc.
- Bio Vision
- Mybiosource
For instance,
- In June 2023, Fortress Diagnostics created awareness with a focus on men’s health testing awareness month and posted an article on diabetes and a higher risk of diabetes due to reduced rates of weight gain and accumulation of fat.
Fructosamine Test Market
By Disease Indication:
- Diabetes I
- Diabetes II
- Gestational Diabetes
By Sample:
- Blood Serum
- Blood Plasma
By Application:
- Clinical Diagnostics for Human
- Clinical Diagnostics for Animals
- Research Use
By End-user:
- Hospitals
- Specialty Clinics
- Veterinary Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
By Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Middle East & Africa
Unleash Potential: Craft Your Customized Report Now:https://www.futuremarketinsights.com/customization-available/rep-gb-7030
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
